University Of Maryland, Baltimore
Clinical trials sponsored by University Of Maryland, Baltimore, explained in plain language.
-
Can a once-weekly antibiotic help people with opioid use disorder beat serious infections at home?
Disease control TerminatedThis trial tests whether a weekly IV antibiotic called oritavancin, given alongside medication for opioid use disorder, can help people finish treatment for serious infections like bloodstream or bone infections without needing to stay in a nursing facility. The study enrolls adu…
Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Proton beam therapy plus chemo aims to improve Post-Surgery treatment for advanced endometrial cancer
Disease control TerminatedThis phase 2 trial tests a new approach called UPPROACH for people with loco-regionally advanced endometrial cancer who have had surgery. The treatment combines intensity-modulated proton beam therapy (IMPT) with standard chemotherapy (carboplatin and paclitaxel) given at the sam…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can Ice-Cold saline save trauma victims in cardiac arrest?
Disease control TerminatedThis study tested a dramatic approach: rapidly cooling trauma patients whose hearts had stopped from severe bleeding. Doctors flushed ice-cold saline into the aorta to induce deep hypothermia, then performed emergency surgery to stop the bleeding before slowly rewarming the patie…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain bleed drug combo study halted after just one patient
Disease control TerminatedThis study looked at whether adding the drug pioglitazone to a keyhole brain surgery (MIPS) could help people recover from a severe bleeding stroke. Only one person took part before the study was stopped early. The goal was to see if the combination was safe and helped clear the …
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Cancer drug tested against COVID-19 in small trial
Disease control TerminatedThis study tested whether imatinib, a drug used for certain cancers, could help hospitalized adults with COVID-19. Participants received either imatinib or a placebo alongside standard care. The trial was stopped early and only included 21 people, so no firm conclusions can be dr…
Phase: PHASE3 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Vitamin-Like supplement tested for diabetic nerve pain – but trial stopped early
Disease control TerminatedThis early-phase trial tested whether nicotinamide riboside (a form of vitamin B3 sold as Niagen) could help repair nerve damage in people with type 2 diabetes or prediabetes. Only 10 participants were enrolled before the study was terminated. The main goal was to measure changes…
Phase: PHASE1, PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Metabolic MRI could spot prostate cancer without a needle
Diagnosis TerminatedThis study tests a new type of MRI scan that uses a special contrast agent called hyperpolarized pyruvate to see how prostate cells use energy. The goal is to safely distinguish cancerous from normal tissue in men with suspected or known prostate cancer. Participants receive the …
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
Gum treatment may slow memory loss in seniors
Prevention TerminatedThis study looked at whether intensive treatment for gum disease (periodontitis) could prevent dementia in older adults who already have mild cognitive impairment and narrowed neck arteries. Participants received either standard dental care or deep cleaning and root planing. The …
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Exercise and diet tested for chemo nerve damage – but study halted early
Symptom relief TerminatedThis study tested whether a 12-week program of walking and resistance exercises or nutrition education could reduce nerve pain caused by platinum chemotherapy. The trial enrolled 36 adults with cancer who were receiving oxaliplatin or cisplatin. The study was terminated early, so…
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 08:14 UTC
-
Weight may influence breast cancer drug response, study suggests
Knowledge-focused TerminatedThis study looked at whether body weight affects how breast cancer responds to aromatase inhibitors (AIs) like Anastrozole and Letrozole. Researchers gave standard doses of these drugs to 42 postmenopausal women with hormone-sensitive breast cancer before surgery. The goal was to…
Phase: NA • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:07 UTC